ANCAP POSITIVE GLOMERULOPATHY PREVALENCE IN GRAVES' DISEASE PATIENTS IN USE OF ANTI-THYROID DRUGS

被引:0
|
作者
Pereira, Benedito Jorge [1 ]
Gelmetti, Adriana Peixoto [1 ]
Mannis, Alexandre Augusto [1 ]
Nastri, Aderbal Angelo [1 ]
机构
[1] Brigadeiro Hosp, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A49 / A49
页数:1
相关论文
共 50 条
  • [31] EFFECT OF ANTI-THYROID DRUGS ON LYMPHOCYTE BLASTOGENESIS AND SUPPRESSOR CELL-FUNCTION IN GRAVES PATIENTS AND HEALTHY CONTROLS
    GOLDRAT, N
    SHOHAM, J
    BANK, H
    EISENTEIN, Z
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1980, 16 (12): : 884 - 884
  • [32] Selenium analogues of anti-thyroid drugs
    Roy, Gouriprasanna
    Mugesh, Govindasamy
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2008, 183 (04) : 908 - 923
  • [33] STUDIES OF THYROID-HORMONE AND METHIMAZOLE LEVELS IN PATIENTS WITH GRAVES-DISEASE ON A STANDARDIZED ANTI-THYROID DRUG REGIMEN
    DAHLBERG, PA
    KARLSSON, FA
    LINDSTROM, B
    WIDE, L
    CLINICAL ENDOCRINOLOGY, 1981, 14 (06) : 555 - 562
  • [34] THYROID ANTIBODY LEVELS DURING ANTI-THYROID DRUG-THERAPY OF GRAVES-DISEASE
    CHIOVATO, L
    MACCHIA, E
    MARIOTTI, S
    VITTI, P
    FENZI, GF
    PINCHERA, A
    ANNALES D ENDOCRINOLOGIE, 1978, 39 (05) : A21 - A21
  • [35] Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma
    Danielides, S.
    Mavragani, C. P.
    Katsakoulas, I.
    Zintzaras, E.
    Drosos, A. A.
    Vlachoyiannopoulos, P. G.
    Moutsopoulos, H. M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (04) : 299 - 303
  • [36] HYPO-THYROIDISM AS A LATE SEQUELA IN PATIENTS WITH GRAVES-DISEASE TREATED WITH ANTI-THYROID AGENTS
    WOOD, LC
    INGBAR, SH
    JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05): : 1429 - 1436
  • [37] Lipid Profile Evolution in Graves' Disease Treated with Titration Regimen of Anti-Thyroid Drugs Versus Block and Replace Regimen
    Stancu, Ana-Maria
    Pop, Oana
    Purice, Mariana
    Badiu, Corin
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (10) : 712 - 717
  • [38] RELAPSES OF GRAVES-DISEASE AFTER TREATMENT WITH SYNTHETIC ANTI-THYROID DRUGS - HAS HLA FREQUENCY A PROGNOSTIC VALUE
    ALLANNIC, H
    FAUCHET, R
    LORCY, Y
    GUEGUEN, M
    LEGUERRIER, AM
    GENETET, B
    PRESSE MEDICALE, 1983, 12 (44): : 2797 - 2800
  • [39] THYROID STIMULATING ANTIBODIES (TSAB) IN PATIENTS WITH GRAVES-DISEASE UNDERGOING ANTI-THYROID DRUG-TREATMENT - INDICATORS OF ACTIVITY OF DISEASE
    KARLSSON, FA
    DAHLBERG, PA
    CLINICAL ENDOCRINOLOGY, 1981, 14 (06) : 579 - 585
  • [40] USE OF ANTI-THYROID THERAPY IN THE TREATMENT OF NEOPLASTIC CONDITIONS WITH CYTOTOXIC DRUGS
    DIXIT, VM
    HETTIARATCHI, ESG
    MEDICAL HYPOTHESES, 1979, 5 (12) : 1333 - 1336